Bruce A. Peterson
#176,899
Most Influential Person Now
Bruce A. Peterson's AcademicInfluence.com Rankings
Bruce A. Petersonengineering Degrees
Engineering
#8155
World Rank
#9637
Historical Rank
Biomedical Engineering
#825
World Rank
#838
Historical Rank
Bruce A. Petersonphilosophy Degrees
Philosophy
#10884
World Rank
#14935
Historical Rank
Logic
#7730
World Rank
#9575
Historical Rank
Download Badge
Engineering Philosophy
Bruce A. Peterson's Degrees
- Doctorate Medicine Harvard University
Why Is Bruce A. Peterson Influential?
(Suggest an Edit or Addition)Bruce A. Peterson's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A predictive model for aggressive non-Hodgkin's lymphoma. (1993) (4400)
- Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma. (2006) (1256)
- Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. (1992) (1060)
- Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial. (2003) (461)
- A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: clinical findings and clinicopathologic correlations in 15 patients. (1985) (410)
- Nonrandom chromosome abnormalities in lymphoma. (1983) (338)
- Clinical characteristics of post-transplant lymphoproliferative disorders. (1994) (245)
- Multicentric Castleman's disease. (1993) (223)
- Posttransplant T-cell lymphoproliferative disorders--an aggressive, late complication of solid-organ transplantation. (1996) (164)
- Prolonged subcutaneous administration of recombinant α2b interferon in patients with previously untreated Philadelphia chromosome-positive chronic-phase chronic myelogenous leukemia: Effect on remission duration and survival: Cancer and leukemia group B study 8583 (1993) (159)
- Prolonged single-agent versus combination chemotherapy in indolent follicular lymphomas: a study of the cancer and leukemia group B. (2003) (146)
- Rituximab therapy is effective for posttransplant lymphoproliferative disorders after solid organ transplantation (2005) (141)
- Phase III randomized intergroup trial of subtotal lymphoid irradiation versus doxorubicin, vinblastine, and subtotal lymphoid irradiation for stage IA to IIA Hodgkin's disease. (2001) (138)
- Clonal rearrangement for immunoglobulin and T-cell receptor genes in systemic Castleman's disease. Association with Epstein-Barr virus. (1988) (126)
- Cytogenetic abnormalities predict clinical outcome in non-Hodgkin lymphoma. (1988) (114)
- Long‐term survival of patients with acute myeloid leukemia (1997) (111)
- There are differences in cytogenetic abnormalities among histologic subtypes of the non-Hodgkin's lymphomas (1985) (106)
- Four new recurring translocations in non-Hodgkin lymphoma. (1989) (105)
- Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251. (2001) (104)
- There are differences in cytogenetic abnormalities among histologic subtypes of the non-Hodgkin's lymphomas. (1985) (101)
- Chromosomal abnormalities in acute lymphoblastic leukemia. (1981) (96)
- MOPP/ABV hybrid chemotherapy for advanced Hodgkin's disease significantly improves failure-free and overall survival: the 8-year results of the intergroup trial. (1998) (94)
- Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma (2004) (92)
- Comparison of conventional prognostic indices in patients older than 60 years with diffuse large B‐cell lymphoma treated with R‐CHOP in the US Intergroup Study (ECOG 4494, CALGB 9793): consideration of age greater than 70 years in an elderly prognostic index (E‐IPI) (2010) (89)
- Thirty-Month Complete Response as a Surrogate End Point in First-Line Follicular Lymphoma Therapy: An Individual Patient-Level Analysis of Multiple Randomized Trials. (2017) (85)
- Comparison of psychosocial adaptation of advanced stage Hodgkin's disease and acute leukemia survivors. Cancer and Leukemia Group B. (1998) (80)
- Phenotypic markers and BCL-1 gene rearrangements in B-cell chronic lymphocytic leukemia: a Cancer and Leukemia Group B study. (1993) (79)
- Acute promyelocytic leukemia. Management of the coagulopathy during daunorubicin-prednisone remission induction. (1978) (75)
- Intensive postremission therapy in adults with acute nonlymphocytic leukemia using various dose schedules of ara-C: a progress report from the CALGB. Cancer and Leukemia Group B. (1987) (75)
- Response criteria for NHL: importance of 'normal' lymph node size and correlations with response rates. (2000) (72)
- IN-VITRO GLUCOCORTICOID STUDIES FOR PREDICTING RESPONSE TO GLUCOCORTICOID THERAPY IN ADULTS WITH MALIGNANT LYMPHOMA (1980) (67)
- Castleman disease and associated autoimmune disease (2012) (67)
- Effect of age on therapeutic response and survival in advanced Hodgkin's disease. (1982) (66)
- A successful system of scientific data audits for clinical trials. A report from the Cancer and Leukemia Group B. (1993) (64)
- Treatment of acute nonlymphocytic leukemia in elderly patients. A prospective study of intensive chemotherapy (1977) (62)
- Combination versus successive single agent chemotherapy in lymphocytic lymphoma (1978) (62)
- Glucocorticoid receptors in adult acute lymphoblastic leukemia. (1981) (62)
- PROLONGED MAINTAINED REMISSIONS OF ADULT ACUTE NON-LYMPHOCYTIC LEUKAEMIA (1977) (60)
- True histiocytic lymphoma: histopathologic, immunophenotypic and genotypic analysis (1989) (58)
- Rituximab-CHOP Versus CHOP with or without Maintenance Rituximab in Patients 60 Years of Age or Older with Diffuse Large B-Cell Lymphoma (DLBCL): An Update. (2004) (57)
- Long-term disease-free survival in acute nonlymphocytic leukemia. (1981) (56)
- Prolonged subcutaneous administration of recombinant alpha 2b interferon in patients with previously untreated Philadelphia chromosome-positive chronic-phase chronic myelogenous leukemia: effect on remission duration and survival: Cancer and Leukemia Group B study 8583. (1993) (55)
- Intensive five‐drug combination chemotherapy for adult acute non‐lymphocytic leukemia (1980) (54)
- Risk factors for severe neuropsychiatric toxicity in patients receiving interferon alfa-2b and low-dose cytarabine for chronic myelogenous leukemia: analysis of Cancer and Leukemia Group B 9013. (2000) (51)
- A phase II study of cladribine treatment for fludarabine refractory B cell chronic lymphocytic leukemia: results from CALGB Study 9211 (2003) (49)
- 5-Azacytidine and renal tubular dysfunction. (1981) (49)
- Multicenter clinical trial of mitoxantrone in non-Hodgkin's lymphoma and Hodgkin's disease. (1991) (47)
- Autologous bone marrow transplantation for progressive non-Hodgkin's lymphoma: clinical impact of immunophenotype and in vitro purging. (1991) (46)
- Etoposide, vinblastine, and doxorubicin: an active regimen for the treatment of Hodgkin's disease in relapse following MOPP. Cancer and Leukemia Group B. (1995) (44)
- Hodgkin disease in patients 60 years of age or older. Histologic and clinical features of advanced‐stage disease (1993) (43)
- Positron emission tomography scanning in the setting of post‐transplant lymphoproliferative disorders (2009) (42)
- Post‐transplant lymphoproliferative disorders in lung transplant recipients: 20‐yr experience at the University of Minnesota (2011) (41)
- Opportunistic infections in patients with cancer. (1979) (39)
- True histiocytic lymphoma. (1991) (39)
- Personalized risk prediction for event‐free survival at 24 months in patients with diffuse large B‐cell lymphoma (2016) (39)
- Correlations between immunological phenotype and karyotype in malignant lymphoma. (1986) (38)
- Recombinant alpha-2b-interferon in therapy of previously untreated hairy cell leukemia: long-term follow-up results of study by Cancer and Leukemia Group B. (1995) (38)
- Uncommon subtypes of acute nonlymphocytic leukemia: clinical features and management of FAB M5, M6 and M7. (1987) (38)
- Autologous bone marrow transplantation in non-Hodgkin's lymphoma: monoclonal antibodies plus complement for ex vivo marrow treatment. (1988) (33)
- Dose‐escalated cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) chemotherapy for patients with diffuse lymphoma (2001) (32)
- Nosocomial septicemia in the cancer patient: the influence of central venous access devices, neutropenia, and type of malignancy. (1990) (31)
- Angiotensin converting enzyme inhibitors may be protective against cardiac complications following anthracycline chemotherapy (2010) (30)
- Acute promyelocytic leukemia. Management of the coagulopathy during daunorubicin-prednisone remission induction: Management of the Coagulopathy During Daunorubicin-Prednisone Remission Induction (1978) (29)
- Current treatment of follicular low-grade lymphomas. (1999) (29)
- Value of molecular monitoring during the treatment of chronic myeloid leukemia: a Cancer and Leukemia Group B study. (1997) (28)
- Rituximab-induced changes in hematolymphoid tissues found at autopsy. (2008) (28)
- Sequential karyotypes in non‐Hodgkin lymphoma: Their nature and significance (1990) (27)
- Prognostic factors at relapse for adults with acute myeloid leukemia (1990) (27)
- Central nervous system involvement in acute nonlymphocytic leukemia. A prospective study of adults in remission. (1987) (27)
- Clinical pharmacology of cytarabine in patients with acute myeloid leukemia: a Cancer and Leukemia Group B study (1995) (26)
- A phase III study of anti-B4-blocked ricin as adjuvant therapy post-autologous bone marrow transplant: CALGB 9254 (2011) (25)
- Treatment of refractory and relapsed Hodgkin's disease: intensive chemotherapy and autologous bone marrow or peripheral blood stem cell support. (1990) (25)
- Glucocorticoid receptors and in vitro responses to glucocorticoid in acute nonlymphocytic leukemia. (1981) (25)
- Castleman disease (2007) (24)
- A phase II study of recombinant interleukin-2 with or without recombinant interferon-beta in non-Hodgkin's lymphoma. A study of the Cancer and Leukemia Group B. (1992) (24)
- A randomized comparison of methotrexate dose and the addition of bleomycin to chop therapy for diffuse large cell lymphoma and other non‐Hodgkin's lymphomas cancer and leukemia group B study 7851 (1990) (24)
- Cyclophosphamide, doxorubicin, vincristine, and low‐dose continuous infusion bleomycin in non‐Hodgkin's lymphoma: Cancer and leukemia group B study #7804 (1982) (24)
- Phase II trial of docetaxel in non-Hodgkin's lymphomas: a study of the Cancer and Leukemia Group B. (1997) (23)
- Acute nonlymphocytic leukemia in patients with nodular lymphoma (1977) (22)
- 15;17 Translocation in acute promyelocytic leukemia. (1982) (21)
- Intensive postremission therapy in adults with acute nonlymphocytic leukemia with ara-C by continuous infusion or bolus administration: preliminary results of a CALGB phase I study. (1985) (21)
- Deficiency of neutrophilic granule membrane glycoproteins in the myelodysplastic syndromes: a common deficiency in 216 patients studied by the Cancer and Leukemia Group B. (1997) (21)
- Maintenance rituximab (MR) compared to observation (OBS) after R-CHOP or CHOP in older patients (pts) with diffuse large B-cell lymphoma (DLBCL): An Intergroup E4494/C9793 update (2007) (20)
- High-dose therapy and transplantation in non-Hodgkin's lymphoma. (1999) (19)
- Response of therapy-associated acute nonlymphocytic leukemia to intensive induction chemotherapy. (1985) (19)
- Re-induction of complete remissions in adults with acute non-lymphocytic leukemia. (1981) (19)
- In vitro glucocorticoid studies in human lymphoma: clinical and biologic significance. (1981) (19)
- Indolent B-cell non-Hodgkin's lymphomas. (1997) (18)
- Pilot study of vascular health in survivors of Hodgkin lymphoma (2012) (17)
- Laboratory and clinical studies of biochemical modulation by hydroxyurea. (1992) (17)
- Aging and cancer management Part I: Clinical observations (1979) (17)
- Phase II study of infusional chemotherapy with doxorubicin, vincristine and etoposide plus cyclophosphamide and prednisone (I-CHOPE) in resistant diffuse aggressive non-Hodgkin's lymphoma: CALGB 9255 (2000) (17)
- Vindesine for metastatic malignant melanoma. A phase II trial. (1983) (17)
- High-dose methotrexate for the remission induction of refractory adult acute lymphocytic leukemia. (1978) (16)
- Acute Nonlymphocytic Leukemia in the Elderly: Biology and Treatment (1982) (15)
- Patterns of growth factor usage and febrile neutropenia among older patients with diffuse large B-cell non-Hodgkin lymphoma treated with CHOP or R-CHOP: the Intergroup experience (CALGB 9793; ECOG-SWOG 4494) (2017) (15)
- Glucocorticoid receptors in chronic lymphocytic leukemia. (1985) (15)
- Hodgkin's disease (1993) (14)
- R-CHOP Versus (vs) CHOP Followed by Maintenance Rituximab (MR) Vs Observation In Older Diffuse Large B-Cell Lymphoma (DLBCL) Patients (pts): Long-Term Follow-up of Intergroup E4494/C9793 (2010) (14)
- Quality of life appears similar between survivors of indolent and aggressive non-Hodgkin lymphoma (2011) (14)
- VP 16-213 and cyclophosphamide in the treatment of refractory acute nonlymphocytic leukemia with monocytic features. (1981) (14)
- Prolonged follow‐up after initial therapy with 2‐chlorodeoxyadenosine in patients with indolent non‐Hodgkin lymphoma (2006) (14)
- Early‐onset autoimmune hemolytic anemia after cladribine therapy for Waldenström's macroglobulinemia (2006) (13)
- The role of transplantation in non-Hodgkin's lymphoma. (1994) (13)
- Long‐term survival of patients with acute myeloid leukemia (1997) (12)
- Development of response criteria (rc) for low-grade or follicular lymphomas (lg/f nhl) and application in a 166 patient study (1997) (12)
- Primary CNS plasmablastic lymphoma: Report of a case with CSF cytology, flow cytometry, radiology, histological correlation, and review of the literature (2011) (12)
- Sequential chemotherapy (etoposide, vinblastine, and doxorubicin) and subtotal lymph node radiation for patients with localized hodgkin disease and unfavorable prognostic features (1999) (12)
- Combination trial of subcutaneous recombinant alpha 2 b interferon and oral cyclophosphamide in follicular low-grade non-Hodgkin's lymphoma. (1994) (12)
- Combination chemotherapy in the treatment of follicular low-grade lymphoma. (1993) (11)
- The effects of glucocorticoid therapy on glucocorticoid receptors in leukemia and lymphoma. (1981) (10)
- Long-term survival of patients with Hodgkin's disease. Treatment with cyclophosphamide, vinblastine, procarbazine, and prednisone. (1981) (10)
- The role of radiation therapy in Hodgkin disease: Experience and controversy. The 54th annual Janeway lecture: 1989 (1992) (10)
- Patterns of Growth Factor (GF) Usage and Febrile Neutropenia (FN) among Older Patients (pts) with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with CHOP or R-CHOP: An Intergroup Experience (CALGB 9793, ECOG-SWOG 4494). (2004) (9)
- The effects of glucocorticoid therapy on glucocorticoid receptors in leukemia and lymphoma (1981) (8)
- Delphi-panel analysis of appropriateness of high-dose chemotherapy and blood cell or bone marrow autotransplants in diffuse large-cell lymphoma. (1998) (8)
- Vindesine in bronchogenic carcinoma: a phase II trial. (1982) (8)
- Recombinant interferon-α2b added to oral cyclophosphamide either as induction or maintenance in treatment-naive follicular lymphoma: final analysis of CALGB 8691 (2009) (7)
- A pilot investigation on impact of participation in a long-term follow-up clinic (LTFU) on breast cancer and cardiovascular screening among women who received chest radiation for Hodgkin lymphoma (2018) (7)
- Prognostic factors for therapeutic outcome of diffuse small non‐cleaved cell lymphoma in adults (1994) (7)
- Array-based comparative genomic hybridization characterizes a deletion associated with a t(15;17) in acute promyelocytic leukemia. (2008) (7)
- Development of cutaneous squamous cell carcinoma after prolonged exposure to pegylated liposomal doxorubicin and hand–foot syndrome: a newly recognized toxicity (2019) (7)
- Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Etoposide (CHOPE) for Advanced-Stage Hodgkin's Disease: CALGB 8856 (2001) (6)
- AMOPLACE treatment of intermediate-grade and high-grade malignant lymphoma: a Cancer and Leukemia Group B study. (1993) (6)
- Chromosome abnormalities in malignant lymphoma: biologic and clinical correlations. (1985) (6)
- Serum and urine glycosaminoglycans in myeloid leukemia and myelodysplasia. (1989) (6)
- Phase II study of 9-aminocamptothecin in previously treated lymphomas: results of Cancer and Leukemia Group B 9551 (2009) (6)
- Colorectal Lymphoma: A Contemporary Case Series (2019) (5)
- 5-azactidine and zorubicin for patients with previously treated acute nonlymphocytic leukemia: a Cancer and Leukemia Group B pilot study. (1982) (5)
- Low dose chemotherapy for myelodysplastic syndromes. (1998) (4)
- The scientific data audit system of the cancer and leukemia group B (CALGB) (1992) (4)
- Acute non-lymphocytic leukemia in elderly patients. (1979) (4)
- Chemotherapy With cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP) for hodgkin disease: Fourteen‐year follow‐up results (1988) (4)
- Necrotizing leukoencephalopathy following CHOP chemotherapy. (2008) (4)
- CHROMOSOMAL ABNORMALITIES IN NON-HODGKIN'S MALIGNANT LYMPHOMA11This work was supported by the Coleman Leukemia Research Fund and by NCI grant 17034. (1982) (4)
- Lymphoma of the hands in a patient with rheumatoid arthritis: case report. (2014) (4)
- Phase II study of infusional chemotherapy with doxorubicin, vincristine and etoposide plus cyclophosphamide and prednisone (I-CHOPE) in resistant diffuse aggressive non-Hodgkin's lymphoma: CALGB 9255. Cancer and Leukemia Group B. (2000) (4)
- Outcomes for Elderly Patients (pts) with Follicular Lymphoma (FL) Using Individual Patient Data (IPD) from 5922 Pts in 18 Randomized Controlled Trials (RCTs): a Follicular Lymphoma Analysis of Surrogate Hypothesis (FLASH) Group Study (2016) (4)
- Daunorubicin-prednisone in the treatment of acute nonlymphocytic leukemia. (1981) (3)
- Management of patients with acute non-lymphocytic leukemia who fail first cycle of induction therapy. (1981) (3)
- Sarcoid-like Histiocytic Proliferations in Patients With Lymphoma Can Be FDG-avid Concerning for Refractory or Recurrent Disease. (2019) (3)
- Etoposide in combination as first‐line chemotherapy for advanced Hodgkin disease. A cancer and leukemia group B study (1993) (3)
- Combination chemotherapy with diaziquone and amsacrine in relapsed and refractory acute nonlymphocytic leukemia: a Cancer and Leukemia Group B Study. (1987) (3)
- High dose CHOP: A phase II study of initial treatment in aggressive non-Hodgkin lymphoma. Cancer and Leukemia Group B 9351 (2007) (3)
- Laparotomy in the re-evaluation of patients with advanced Hodgkin's disease. (1981) (3)
- Prognostic Indices in Older DLBCL Patients Receiving R-CHOP: An Analysis of the U.S. Intergroup Study (E4494, CALGB 9793). (2006) (3)
- Differences in Outcomes in Males and Females with Diffuse Large B-Cell Lymphoma with Induction Rituximab and Follicular Lymphoma Treated with Maintenance Rituximab (2012) (3)
- A pilot study evaluating chemotherapy tolerability for breast cancer patients who have received prior treatment and chest radiation for Hodgkin Lymphoma. (2018) (3)
- High dose cyclophosphamide plus recombinant human granulocyte-colony stimulating factor (rhG-CSF) in the treatment of follicular, low grade non-Hodgkin's lymphoma: CALGB 9150. (2001) (2)
- Prognostic factors in follicular lymphoma: a single institution study. (2008) (2)
- High Dose Cyclophosphamide Plus Recombinant Human Granulocyte-colony Stimulating Factor (rhG-CSF) in the Treatment of Follicular, Low Grade Non-Hodgkin's Lymphoma: CALGB 9150 (2001) (2)
- Burkitt lymphoma in pregnancy: two cases of successful treatment and continued fertility; with a review of the literature. (2013) (2)
- Impact of consultation in a long term follow-up clinic on breast cancer and cardiovascular screening in Hodgkin lymphoma survivors. (2015) (2)
- Arterial elasticity in testicular cancer survivors. (2014) (2)
- Bortezomib and Rituximab in the Treatment of Post-Transplant Lymphoproliferative Disorders (2011) (2)
- Autologous bone marrow transplantation in non-Hodgkin's lymphoma (1988) (2)
- Combination trial of subcutaneous interferon alfa-2b and oral cyclophosphamide in favorable histology, non-Hodgkin's lymphoma (2004) (2)
- Cyclophosphamide, doxorubicin, vincristine, and low-dose continuous infusion bleomycin in non-Hodgkin's lymphoma: Cancer and Leukemia Group B Study No. 7804. (1982) (2)
- Prolonged disease-free survival in adult acute non-lymphocytic leukemia (ANLL) (1979) (2)
- Outcomes of older patients with follicular lymphoma using individual data from 5922 patients in 18 randomized controlled trials. (2021) (2)
- Introduction: Benign lymphoproliferative disorders (1993) (1)
- A Multistate Survival Analysis for Patients with Follicular Lymphoma (FL) Using 13 First-Line Randomized Trials from FL Analysis of Surrogate Hypothesis (FLASH) Group (2019) (1)
- Acute nonlymphocytic leukemia in adults. When diagnosis and pretreatment assessment can't wait. (1983) (1)
- Patterns of relapse following chemotherapy in non-Hodgkin's lymphoma (1983) (1)
- Banded chromosome abnormalities in non-Hodgkin’s lymphoma. Correlations with morphology, immunologic phenotype and clinical course (1985) (1)
- Vindesine (VDS) in bronchogenic carcinoma: A phase II trial (1981) (1)
- Therapy of Hodgkin's disease (HD) with cyclophosphamide, vinblastine, procarbazine, prednisone (CVPP): 5 year follow-up (1979) (1)
- Arterial elasticity as a risk factor for early cardiovascular disease among testicular cancer survivors treated with platinum-based chemotherapy: a cross-sectional pilot study (2018) (1)
- Nonrandom Chromosome Abnormalities in Lymphoma 1 (2006) (1)
- Duration of dna inhibition by hydroxyurea. Abstr. (1970) (1)
- Severe renal tubular dysfunction during 5-azacytidine chemotherapy (1979) (1)
- Group B study 8583 (see comments) effect on remission duration and survival: Cancer and Leukemia chromosome-positive chronic-phase chronic myelogenous leukemia: interferon in patients with previously untreated Philadelphia Prolonged subcutaneous administration of recombinant alpha 2b (2011) (1)
- CLINICAL CHARACTERISTICS AND TREATMENT OUTCOMES FOR YOUNG PATIENTS WITH FIRST‐LINE FOLLICULAR LYMPHOMA: A POOLED ANALYSIS OF 4249 PATIENTS FROM THE FLASH DATABASE. (2017) (1)
- IPI24 supplemental material submitted (2015) (0)
- Author's reply: Estrogens for breast cancer? (1980) (0)
- Do ACE-I protect against the development of doxorubicin cardiac toxicity? (2009) (0)
- PREVALENCE AND SIGNIFICANCE OF LYMPHOPROLIFERATIVE DISORDERS AFTER SOLID ORGAN TRANSPLANTS: 840 (2008) (0)
- 126 Risk factors for febrile neutropemia among older patients with diffuse large B-cell non-Hodgkin's lymphoma (DLBCL) treated with anthracycline-based chemotherapy (2006) (0)
- Investigational new drugs in cancer chemotherapy. (1979) (0)
- Post Transplant Lymphoproliferative Disorders (PTLD) After Lung Transplantation: Comparison of Patients with Early Versus Late Disease. (2009) (0)
- Quality of Life in Non-Hodgkin Lymphoma: A Comparison Between Survivors of Indolent and Aggressive Disease. (2009) (0)
- Randomized C omparison o f A BVD a nd M OPP/ABV H ybrid f or the T reatment o f A dvanced H odgkin's D isease: R eport o f a n Intergroup T rial (2003) (0)
- Blood Disorders in the Elderly: Non-Hodgkin lymphoma (2007) (0)
- Glucocorticoid Receptors in Adult Acute Lymphoblastic Leukemia1 (2006) (0)
- Evaluation of chemotherapy tolerability for breast cancer patients who have received radiation as treatment for a prior Hodgkin lymphoma. (2016) (0)
- CALGB Studies with Hematopoietic Growth Factors in Patients with AML (1992) (0)
- SOFTWARE FOR WRITING INSTRUCTION. (1984) (0)
- Clonal Rearrangementfor Imnmunoglobulin and T-Cell Receptor Genes in Systemic Castleman's Disease Association With Epstein-Barr Virus (2007) (0)
- Prognostic factors in follicular lymphoma: A single-institution study (2005) (0)
- Disease-Free Survival in Acute Nonlymphocytic Leukemia (2016) (0)
- Prolonged S ingle-Agent V ersus C ombination C hemotherapy i n Indolent F ollicular L ymphomas: A S tudy o f t he C ancer a nd Leukemia G roup B (2003) (0)
- Positron Emission Tomography (PET) Scanning in the Setting of Post-Transplant Lymphoproliferative Disorders (PTLD). (2007) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Bruce A. Peterson?
Bruce A. Peterson is affiliated with the following schools:
